ICD-10-CM Billable Code

M85.079

Fibrous dysplasia (monostotic), unspecified ankle and foot

Clinical Classification Guidelines

Medical Intelligence & Overview

Fibrous dysplasia is a bone disorder where normal bone is replaced with fibrous tissue, leading to weakened bones and potential deformities. When this condition affects a single bone or a specific area, it's called monostotic fibrous dysplasia. In cases involving the ankle and foot, this condition can impact mobility and cause discomfort. Although it is a benign condition, its effects on bone integrity can be significant. Proper diagnosis and management are essential to maintaining quality of life and preventing complications.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting bone development, often involving GNAS gene alterations. Sporadic development without any identifiable hereditary link. No clear environmental or lifestyle factors have been linked directly to the onset of fibrous dysplasia.

Key Symptoms: Bone pain or tenderness, particularly in affected areas. Swelling or palpable lumps around the ankle or foot. Deformities or irregularities in the shape of the affected bones. Reduced mobility or difficulty walking if the foot or ankle are significantly affected. Possible fractures due to bone fragility in severe cases.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of fibrous dysplasia typically involves a combination of clinical assessment, imaging studies, and sometimes biopsy: - **Medical history and physical examination** to identify symptoms and physical signs. - **X-rays** to visualize the affected bones, often revealing characteristic areas of radiolucency with a “ground-glass” appearance. - **MRI or CT scans** may be used for detailed imaging and to evaluate the extent of bone involvement. - **Bone biopsy** may be performed to confirm the diagnosis and rule out other bone pathologies. - **Laboratory tests** are generally not diagnostic but may be used to exclude other conditions. Accurate diagnosis helps in differentiating fibrous dysplasia from other bone diseases such as tumors or infections.

Treatment Protocols: Management of fibrous dysplasia focuses on alleviating symptoms and maintaining bone strength: - **Observation and monitoring** if the condition is mild and asymptomatic. - **Pain management** with medications such as NSAIDs. - **Surgical intervention** may be necessary in cases involving deformity, fracture, or persistent pain; procedures can include curettage, bone grafting, or corrective osteotomy. - **Physical therapy** to improve mobility and strengthen surrounding muscles. - **Bisphosphonates** have been used in some cases to help decrease bone pain and stabilize bone lesions. - Regular follow-up with imaging to monitor disease progression and response to treatment. While there is no cure for fibrous dysplasia, these approaches can help manage symptoms and improve function. The prognosis varies depending on the extent of bone involvement and response to treatment.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M85.079 a billable ICD-10 code?
Yes, M85.079 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M85.079?
Clinical documentation must specify the nature of Fibrous dysplasia (monostotic), unspecified ankle and foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference